A person with symptoms of a liver problem may need to undergo a liver biopsy to determine the cause. A doctor can then make treatment recommendations based on the liver biopsy results. Liver biopsies ...

Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...

Fatty liver disease happens when too much fat builds up in the liver. Metabolic dysfunction-associated steatohepatitis (MASH) is a severe type of fatty liver disease where fat buildup causes liver ...

Data regarding risk factors and long-term outcomes of U.S. patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. This study aimed to investigate the ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Although percutaneous liver biopsy is still the “gold standard,” advances in techniques and ...

A liver biopsy is a test that allows doctors to examine tissue from the liver under a microscope. It can test for several severe medical conditions, including cancer. A doctor may recommend a liver ...

Novel non-invasive liver disease assessments (NILDAs) are effective alternatives to liver biopsy for the treatment of liver ...

Cholesterol crystals in the liver may stiffen the organ early in those with metabolic dysfunction-associated steatotic liver disease (MASLD)—well before scarring develops—according to new research ...

Hepatitis C virus (HCV) has multiple genotypes of which genotype 1 is the most common in the United States. Cirrhosis does not develop in all patients infected with HCV. Elevated serum ...

The FDA has officially approved the first AI tool to help with liver disease drug trials, and it is designed to make reading liver biopsies for MASH faster, more consistent, and easier for ...